KYORIN Pharmaceutical Co., Ltd.

OTCPK:KYRN.F Stock Report

Market Cap: US$528.7m

KYORIN Pharmaceutical Management

Management criteria checks 1/4

KYORIN Pharmaceutical's CEO is Yutaka Ogihara, appointed in Jun 2019, has a tenure of 5.58 years. directly owns 13.63% of the company’s shares, worth $72.06M. The average tenure of the management team and the board of directors is 1 years and 6.6 years respectively.

Key information

Yutaka Ogihara

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.6yrs
CEO ownership13.6%
Management average tenureless than a year
Board average tenure6.6yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Yutaka Ogihara (57 yo)

5.6yrs

Tenure

Mr. Yutaka Ogihara has been Representative Director and President of KYORIN Pharmaceutical Co., Ltd. since June 2019 and serves as its Chief Executive Officer since April 2023. He serves as Chairman of KYO...

Leadership Team

NamePositionTenureCompensationOwnership
Yutaka Ogihara
President5.6yrsno data13.63%
$ 72.1m
Yasuji Kurose
CFO, CStOno datano data0.00050%
$ 2.6k
Junichi Ishiyama
Executive Officerno datano datano data
Kiyoo Uehara
Executive Officerless than a yearno datano data
Michiro Onota
Executive Director & CMOno datano data0.025%
$ 133.2k
Takaaki Kaji
Executive Officer & Chief Business Development Officerno datano datano data
Noriaki Tamura
Executive Officerno datano datano data
Kimiya Masada
Corporate Officer & Director of Product Strategyless than a yearno datano data
Hiroshi Hashizume
Executive Officerno datano datano data
Makoto Yanai
Executive Officer & Deputy GM of Business Development Divisionno datano datano data
Katsuhiro Hamada
Executive Officer & GM of Reliability Assurance Headquartersno datano datano data

1.0yrs

Average Tenure

Experienced Management: KYRN.F's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Yutaka Ogihara
President13.6yrsno data13.63%
$ 72.1m
Yasuji Kurose
CFO, CStOless than a yearno data0.00050%
$ 2.6k
Michiro Onota
Executive Director & CMO7.6yrsno data0.025%
$ 133.2k
Hiroshi Hashizume
Executive Officerno datano datano data
Tomiharu Matsumoto
Chairman of Corporate Auditors6.6yrsno data0.036%
$ 191.4k
Kenji Akutsu
Full-time Audit & Supervisory Board Member2.6yrsno data0.023%
$ 120.1k
Takao Yamaguchi
Outside Audit & Supervisory Board Member9.6yrsno data0.0043%
$ 23.0k
Noriyuki Shikanai
Independent Outside Director11.6yrsno data0.0085%
$ 45.1k
Ken Shigematsu
Independent Outside Director7.6yrsno data0.0082%
$ 43.2k
Hiromi Watanabe
Independent Outside Director5.6yrsno data0.0040%
$ 21.1k
Yukio Ikemura
Outside Audit & Supervisory Board Member2.6yrsno data0.00087%
$ 4.6k
Kensuke Morita
Outside Audit & Supervisory Board Member2.6yrsno data0.00087%
$ 4.6k

6.6yrs

Average Tenure

69yo

Average Age

Experienced Board: KYRN.F's board of directors are considered experienced (6.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 21:26
End of Day Share Price 2024/10/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

KYORIN Pharmaceutical Co., Ltd. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ritsuo WatanabeBofA Global Research
Hidemaru YamaguchiCitigroup Global Markets Japan Inc.
Hidemaru YamaguchiCitigroup Inc